Literature DB >> 305462

Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

N N Iscove, F Melchers.   

Abstract

Albumin, transferrin, and lipids can replace serum entirely for support of LPS-stimulated murine B lymphocytes in culture. In the presence of these compounds, growth and maturation to IgM and IgG secretion, induced by lipopolysaccharide (LPS), occurs at the same or higher efficiency in serum-free conditions as in conventional serum-containing medium, even at relatively low cell concentrations. In contrast to the rapid disappearance of LPS reactivity in conventional serum-containing medium, responsiveness remains at initial levels in serum-free conditions for 2 days before slowly declining. Overall lymphocyte survival is also markedly prolonged. In the presence of thymus "filler" cells, the serum-free conditions permit growth of every LPS-responsive cell to a clone of Ig-secreting cells at dilutions as low as a single reactive B cell per culture. The results have several important implications. These include the establishment for the first time of transferrin as a requirement for B lymphocyte responses in culture, and the availability now of conditions for the assay isolation of cell products regulating lymphocyte function, free of interference from undefined serum components.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305462      PMCID: PMC2184195          DOI: 10.1084/jem.147.3.923

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Identification of albumin as the serum factor essential for the growth of activated human lymphocytes.

Authors:  H Spieker-Polet; H Polet
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

2.  Interaction of phosphatidylcholine with bovine serum albumin. Specificity and properties of the complexes.

Authors:  A Jonas
Journal:  Biochim Biophys Acta       Date:  1976-03-18

3.  IgM in bone marrow-derived lymphocytes. Synthesis, surface deposition, turnover and carbohydrate composition in unstimulated mouse B cells.

Authors:  J Andersson; L Lafleur
Journal:  Eur J Immunol       Date:  1974-03       Impact factor: 5.532

4.  Leakage of sucrose from phosphatidylcholine liposomes induced by interaction with serum albumin.

Authors:  J Zborowski; F Roerdink; G Scherphof
Journal:  Biochim Biophys Acta       Date:  1977-03-29

5.  Role of bovine serum albumin in blastoid transformation of lymphocytes by phytohemagglutinin.

Authors:  S Arai; I Yamane; Y Tanno; T Takishima
Journal:  Proc Soc Exp Biol Med       Date:  1977-03

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

7.  Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte.

Authors:  J Andersson; A Coutinho; W Lernhardt; F Melchers
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

8.  Development of methods for the quantitative in vitro analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells.

Authors:  E R Stanley; R E Palmer; U Sohn
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

9.  Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages.

Authors:  J Andersson; A Coutinho; F Melchers
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

10.  The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule.

Authors:  J Andersson; F Melchers; C Galanos; O Lüderitz
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  116 in total

1.  The myeloproliferative sarcoma virus causes transformation or erythroid progenitor cells in vitro.

Authors:  W D Hankins; T A Kost; I B Pragnell
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

2.  Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free medium.

Authors:  F Dhainaut; N Bihoreau; J L Meterreau; J Lirochon; R Vincentelli; G Mignot
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells.

Authors:  P M Castro; P M Hayter; A P Ison; A T Bull
Journal:  Appl Microbiol Biotechnol       Date:  1992-10       Impact factor: 4.813

Review 4.  Nutrient optimization for high density biological production applications.

Authors:  D W Jayme
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

5.  Clonogenic assay of leukemic cells in serum-free culture.

Authors:  Y C Dai; X Q Lu; Z Fang
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

6.  The optimization of serum-free medium for the production of the scu-PA by the addition of algal extracts.

Authors:  H G Kim; K D Sung; M S Ham; K H Chung; K H Chung; H Y Lee
Journal:  Cytotechnology       Date:  1995-10       Impact factor: 2.058

7.  Monoclonal antibodies to human prostatic acid phosphatase: probes for antigenic study.

Authors:  H S Lillehoj; B K Choe; N R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro.

Authors:  J A Hatzfeld; A Hatzfeld; J Maigne
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Transferrin binding and iron uptake by mouse lymph node cells during transformation in response to concanavalin A.

Authors:  J H Brock; M C Rankin
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

10.  Primary in vitro plaque-forming cell response to DAGG-Ficoll: LPS-induced enhancement mediated by interleukin-1.

Authors:  J L Curtis; A A Nordin
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.